SARAH ELLIOTT: Open Payments
NPI 1649635517 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,157 in 89 payments from 21 companies in 2025. Trend: 2023 $2,003 · 2024 $1,659 · 2025 $2,157
Food & beverage: $2,100Education: $57
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $389 |
| GlaxoSmithKline, LLC. | 22 | $373 |
| Regeneron Healthcare Solutions, Inc. | 10 | $237 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $234 |
| Verona Pharma, Inc. | 8 | $164 |
| Lilly USA, LLC | 2 | $138 |
| Axsome Therapeutics, Inc. | 5 | $96 |
| Merck Sharp & Dohme LLC | 3 | $78 |
| Grifols USA, LLC | 3 | $70 |
| Baxter Healthcare | 3 | $69 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, OFEV, TRELEGY ELLIPTA, ZEPBOUND, Sunosi, WINREVAIR.
Industry payments across GA — which companies pay providers there.
